The vast majority of SMA cases (95%) are due to a homozygous deletion in the survival motor neuron 1 (SMN1) gene, which leads to a decrease in the functional SMN protein and ultimately leads to patients developing SMA. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.